BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25081544)

  • 1. Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.
    Kendall RT; Lee MH; Pleasant DL; Robinson K; Kuppuswamy D; McDermott PJ; Luttrell LM
    J Biol Chem; 2014 Sep; 289(38):26155-26166. PubMed ID: 25081544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.
    Wilson PC; Lee MH; Appleton KM; El-Shewy HM; Morinelli TA; Peterson YK; Luttrell LM; Jaffa AA
    J Biol Chem; 2013 Jun; 288(26):18872-84. PubMed ID: 23661707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
    Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
    J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling network.
    Kendall RT; Strungs EG; Rachidi SM; Lee MH; El-Shewy HM; Luttrell DK; Janech MG; Luttrell LM
    J Biol Chem; 2011 Jun; 286(22):19880-91. PubMed ID: 21502318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. {beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation.
    Ahn S; Kim J; Hara MR; Ren XR; Lefkowitz RJ
    J Biol Chem; 2009 Mar; 284(13):8855-65. PubMed ID: 19171933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
    Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
    Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
    Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II activates NF-κB through AT1A receptor recruitment of β-arrestin in cultured rat vascular smooth muscle cells.
    Morinelli TA; Lee MH; Kendall RT; Luttrell LM; Walker LP; Ullian ME
    Am J Physiol Cell Physiol; 2013 Jun; 304(12):C1176-86. PubMed ID: 23576578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
    Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
    BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
    Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
    Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways.
    Gerasimovskaya EV; Tucker DA; Weiser-Evans M; Wenzlau JM; Klemm DJ; Banks M; Stenmark KR
    J Biol Chem; 2005 Jan; 280(3):1838-48. PubMed ID: 15522879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.
    Furusho M; Ishii A; Bansal R
    J Neurosci; 2017 Mar; 37(11):2931-2946. PubMed ID: 28193689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR).
    Xiao K; Sun J; Kim J; Rajagopal S; Zhai B; Villén J; Haas W; Kovacs JJ; Shukla AK; Hara MR; Hernandez M; Lachmann A; Zhao S; Lin Y; Cheng Y; Mizuno K; Ma'ayan A; Gygi SP; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15299-304. PubMed ID: 20686112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II activates Ca
    Kashihara T; Nakada T; Kojima K; Takeshita T; Yamada M
    J Physiol; 2017 Jul; 595(13):4207-4225. PubMed ID: 28295363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts.
    Aplin M; Christensen GL; Schneider M; Heydorn A; Gammeltoft S; Kjølbye AL; Sheikh SP; Hansen JL
    Basic Clin Pharmacol Toxicol; 2007 May; 100(5):289-95. PubMed ID: 17448113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
    Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
    J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
    Julien LA; Carriere A; Moreau J; Roux PP
    Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.